OJBD  Vol.6 No.1 , March 2016
Alterations in D-Dimer, Prothrombin Time and Activated Partial Thromboplastin Time as Thrombogenesis Activity Markers in Patients with Acute Myocardial Infarction
Cardiovascular disease remains the leading cause of mortality and morbidity despite the identification of major risk factors and risk reduction strategies. Myocardial infarction (MI) is a relevant cardiovascular worldwide event for morbidity and mortality. In most cases, sudden cardiac death is triggered by ischemia-related ventricular tachyarrhythmia and accounts for 50% of deaths from cardiovascular disease in developed countries. This is a descriptive analytical case control study aimed to determine D-dimer, PT and PTT level and among patients with acute myocardial infarction conducted in Sudan cardiac center hospital. Thirty patients after MI and twenty normal controls have been studied. The MI patients also include co-exist disease diabetes and hypertension, they receive different anticoagulants therapy. The result demonstrates a significant increase post MI in the mean level of D-dimer (p = 0.00) whereas none significantly compares to control group. There are no differences between INR (0.393), PTT (0.648) and PT (0.393), parameters between cases and controls. In conclusion, our study reveals higher D-dimer level among patients than the control. In conclusion, serum D-dimer levels appear to be useful for diagnosing MI and may assist in the prediction of mortality among those patients which are presented with acute chest pain or known diagnosed with MI and should be done as indicator for thrombosis risk during therapy in post MI.
Cite this paper
Ali, N. , Gameel, F. , Elsayid, M. and Babker, A. (2016) Alterations in D-Dimer, Prothrombin Time and Activated Partial Thromboplastin Time as Thrombogenesis Activity Markers in Patients with Acute Myocardial Infarction. Open Journal of Blood Diseases, 6, 1-5. doi: 10.4236/ojbd.2016.61001.
[1]   Falk, E., Shah, P.K. and Fuster, V. (1995) Coronary Plaque Disruption. Circulation, 92, 657-671.

[2]   Hernandez, L.M. and Blazer, D.G. (2006) Genetic, Environmental, and Personality Determinants of Health Risk Behaviors. The National Academies Press (NAP), USA.

[3]   MI, Myocardial Infarction.

[4]   Li, Y.H., Teng, J.K., Tsai, W.C., Tsai, L.M., Lin, L.J., Guo, H.R. and Chen, J.H. (1999) Prognostic Significance of Elevated Hemostatic Markers in Patients with Acute Myocardial Infarction. Journal of the American College of Cardiology, 33, 1543-1548.

[5]   Lowe, G. (2005) Fibrin D-Dimer and Cardiovascular Risk. Seminars in Vascular Medicine, 5, 387-398.

[6]   Khan, H.A., Alhomida, A.S., Rammah, T.Y.A., Sobki, S.H., Ola, M.S. and Khan, A.A. (2013) Alterations in Prothrombin Time and Activated Partial Thromboplastin Time in Patients with Acute Myocardial Infarction. International Journal of Clinical and Experimental Medicine, 6, 294-297.

[7]   Ardissino, D., Merlini, P.A., Bauer, K.A., Galvani, M., Ottani, F., Franchi, F., Bertocchi, F., Rosenberg, R.D. and Manucci, P.M. (2003) Coagulation Activation and Long-Term Outcome in Acute Coronary Syndromes. Blood, 102, 2731- 2735. http://dx.doi.org/10.1182/blood-2002-03-0954

[8]   Miller, G.J., Ireland, H.A., Cooper, J.A., Bauer, K.A., Morrissey, J.H., Humphries, S.E. and Esnouf, M.P. (2008) Relationship between Markers of Activated Coagulation, Their Correlation with Inflammation, and Association with Coronary Heart Disease (NPHSII). Journal of Thrombosis and Haemostasis, 6, 259-267. http://dx.doi.org/10.1111/j.1538-7836.2007.02819.x

[9]   Lip, G.Y. (2000) Hypertension and the Prothrombotic State. Journal of Thrombosis and Haemostasis, 14, 687-690. http://dx.doi.org/10.1038/sj.jhh.1001051

[10]   Ruberg, F.L. and Loscalzo, J. (2002) Prothrombotic Determinants of Coronary Atherothrombosis. Vascular Medicine, 7, 289-299. http://dx.doi.org/10.1191/1358863x02vm448ra

[11]   Ridker, P.M., Hennekens, C.H., Cerskus, A. and Stampfer, M.J. (1994) Plasma Concentrations of Cross-Linked Fibrin Degradation Product (D-Dimer) and the Risk of Future Myocardial Infarction among Apparently Healthy Men. Circulation, 90, 2236-2240.

[12]   Gurfinkel, E., Bozovich, G., Cerdá, M., et al. (1995) Time Significance of Acute Thrombotic Reactant Markers in Patients with and without Silent Myocardial Ischemia and Overt Unstable Angina Pectoris. American Journal of Cardiology, 76, 121-124. http://dx.doi.org/10.1016/S0002-9149(99)80042-3

[13]   Lee, L.V., Ewald, G.A., McKenzie, C.R., et al. (1997) The Relationship of Soluble Fibrin and Cross-Linked Fibrin Degradation Products to the Clinical Course of Myocardial Infarction. Arteriosclerosis, Thrombosis, and Vascular Biology, 17, 628-633. http://dx.doi.org/10.1161/01.ATV.17.4.628

[14]   Barber, M., Langhorne, P., Rumley, A., Lowe, G.D. and Stott, D.J. (2004) Hemostatic Function and Progressing Ischemic Stroke: D-Dimer Predicts Early Clinical Progression. Stroke, 35, 1421-1425.

[15]   Zi, W.J. and Jie, S. (2014) Plasma D-Dimer Levels Are Associated with Stroke Subtypes and Infarction Volume in Patients with Acute Ischemic Stroke. PLoS ONE, 9, e86465.

[16]   Uzuki, T., Yamauchi, K., Yamada, Y., Furumichi, T., Furui, H., Tsuzuki, J., Hayashi, H., Sotobata, I. and Saito, H. (1992) Blood Coagulability and Fibrinolytic Activity before and after Physical Training during the Recovery Phase of Acute Myocardial Infarction. Clinical Cardiology, 15, 358-364.

[17]   Granger, C.B., Hirsch, J., Califf, R.M., Col, J., White, H.D., Betriu, A., Woodlief, L.H., Lee, K.L., Bovill, E.G., Simes, R.J. and Topol, E.J. (1996) Activated Partial Thromboplastin Time and Outcome after Thrombolytic Therapy for Acute Myocardial Infarction: Results from the GUSTO-I Trial. Circulation, 93, 870-878. http://dx.doi.org/10.1161/01.CIR.93.5.870